HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamide

a transient receptor potential vanilloid 4 channel agonist; structure in first source
Also Known As:
GSK 1016790A; GSK-1016790A; GSK1016790A
Networked: 22 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kato, Shinichi: 2 articles (01/2018 - 01/2018)
2. Matsumoto, Kenjiro: 2 articles (01/2018 - 01/2018)
3. Ding, Xinli: 1 article (08/2021)
4. Fan, Xiaohua: 1 article (08/2021)
5. Han, Junting: 1 article (08/2021)
6. Ning, Liping: 1 article (08/2021)
7. Tang, Shaocan: 1 article (08/2021)
8. Wang, Chuanwei: 1 article (08/2021)
9. Asao, Yasunori: 1 article (01/2020)
10. Cui, Yuan-Yuan: 1 article (01/2020)

Related Diseases

1. Inflammation (Inflammations)
2. Liver Cirrhosis (Hepatic Cirrhosis)
3. Shock
4. Neoplasms (Cancer)
5. Necrosis

Related Drugs and Biologics

1. HC-067047
2. Carbon Tetrachloride (Tetrachloromethane)
3. cadherin 5
4. Therapeutic Uses
5. NG-Nitroarginine Methyl Ester (L-NAME)
6. Nitric Oxide Synthase (NO Synthase)
7. Cytokines
8. Interleukin-6 (Interleukin 6)
9. Trifluoperazine (Stelazine)
10. Ruthenium Red

Related Therapies and Procedures

1. Intraperitoneal Injections
2. Intravenous Administration
3. Oral Administration